{
  "ptid_time": "033_S_5087_2013-05-24",
  "img_path": "/data/qiuhui/data/adni/images/033_S_5087/2013-05-24/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 57,632 mm³, 158.0% above the reference mean. With a Z-score of 3.95 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 6,353 mm³, 17.3% below the reference mean. With a Z-score of -1.94 (2.6th percentile), this represents moderate atrophy; whole brain volume measures 972,530 mm³, 5.5% below the reference mean. With a Z-score of -0.69 (24.7th percentile), this represents normal volume ; entorhinal cortex volume measures 2,851 mm³, 26.8% below the reference mean. With a Z-score of -2.07 (1.9th percentile), this represents significant atrophy; fusiform gyrus volume measures 16,045 mm³, 11.9% below the reference mean. With a Z-score of -1.34 (9.0th percentile), this represents mild atrophy; middle temporal gyrus volume measures 17,439 mm³, 15.0% below the reference mean. With a Z-score of -1.33 (9.1th percentile), this represents mild atrophy. ",
  "text_data": "Age is 64.6 years. Gender is Female. Education: 17 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Major Surgical Procedures. MMSE: 25.0. MoCA: 14.0. Logical Memory: 0.0. Laboratory findings: Total Bilirubin: 1.40 (profound elevated); Direct Bilirubin: 0.30 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.50 SUVR (profound elevated); Amyloid beta: 639.10 pg/mL (mild reduced); Total tau: 424.60 pg/mL (significant elevated); Phosphorylated tau: 41.32 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound ventricular enlargement, significant hippocampal and entorhinal cortex atrophy, and mild atrophy in the fusiform and middle temporal gyri—all hallmarks of neurodegeneration. Combined with cognitive impairment (MoCA 14, MMSE 25), elevated biomarkers (Aβ reduction, elevated tau, and AV45), this strongly suggests Alzheimer's pathology despite the absence of APOE4.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Key red flags: Entorhinal/hippocampal atrophy + tau/Aβ biomarkers + severe cognitive deficits. MoCA <18 typically indicates dementia, and MMSE 25 is borderline impaired. Biomarkers and atrophy pattern override APOE4 negativity.)*",
  "timestamp": "2025-07-26T05:38:08.405774"
}